Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Canada Research Chairs

McGill University

$120,000.00

Biomaterials and Biomacromolecule Delivery

FY 2024-25

Summary
The applications of biomacromolecules are diverse and expansive, spanning fields from basic research to bioengineering, food science, and healthcare. However, the practical use of these biomacromolecules is limited by challenges such as susceptibility to degradation, lack of cell/tissue targeting, and inability to enter cells. The development of drug delivery technologies has enabled the delivery of biomacromolecules to cells or tissues, enhancing their efficacy while reducing side effects. The recent mRNA vaccines for COVID-19 are a prime example of the importance of drug delivery technologies in exploiting biomacromolecules for practical applications, with tremendous impact on public health and the economy. Despite recent advances, several major challenges still exist in developing drug delivery systems for biomacromolecules, including low encapsulation and delivery efficiency, inefficient cell/tissue targeting, and the need for cold chains for long-term storage and wide distribution. The development of advanced drug delivery systems for biomacromolecules with improved efficiency of cargo encapsulation, efficient and precise cell targeting efficiency and superior stability for long-term storage and ease of global distribution is therefore crucial. Such technology for drug delivery would allow full realization of the transformative potential of biomacromolecules to prevent and treat disease. Dr. Chen’s research program aims to develop next-generation drug delivery systems for biomacromolecules by advancing materials design and nanofabrication technologies, as well as gaining a deeper knowledge of interactions between biomaterials and biological systems. The research program is divided into three themes, including novel nanocarriers for efficient and precise CRISPR-Cas9 delivery, advanced lipid nanoparticles for gene delivery, and bioresponsive nanoformulations for programmable protein delivery. The proposed research aligns exceptionally well with key aspects of McGill University’s Strategic Research Plan, including research pillars and strategic themes focused on nanoscience and advancing the biomedical and health sciences for healthy populations, and core commitments to fostering creativity and promoting equity, diversity, and inclusion (EDI) in research. With his multidisciplinary expertise and the support of the CRC program, Dr. Chen is well-positioned to make significant contributions to the field of biomaterials and biomacromolecule delivery.
Program
Canada Research Chairs
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
CRC-2023-00007
Name nom
Chen, Guojun
Department département
Biomedical Engineering - McGill University
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
120000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF2070101
Field of research list names en
Biomedical materials
Field of research list names fr
Matériaux biomédicaux
Socioeconomic objective list codes
RDS10701
Socioeconomic objective list names en
Human health procedures and pharmaceutical treatments
Socioeconomic objective list names fr
Interventions et traitements pharmaceutiques ayant trait à la santé humaine
Application title
Biomaterials and Biomacromolecule Delivery
Keywords
Biomaterials; Biomacromolecules; Drug delivery; Nanotechnology; Materials Science; Gene delivery; Nanomaterials
Application summary
The applications of biomacromolecules are diverse and expansive, spanning fields from basic research to bioengineering, food science, and healthcare. However, the practical use of these biomacromolecules is limited by challenges such as susceptibility to degradation, lack of cell/tissue targeting, and inability to enter cells. The development of drug delivery technologies has enabled the delivery of biomacromolecules to cells or tissues, enhancing their efficacy while reducing side effects. The recent mRNA vaccines for COVID-19 are a prime example of the importance of drug delivery technologies in exploiting biomacromolecules for practical applications, with tremendous impact on public health and the economy. Despite recent advances, several major challenges still exist in developing drug delivery systems for biomacromolecules, including low encapsulation and delivery efficiency, inefficient cell/tissue targeting, and the need for cold chains for long-term storage and wide distribution. The development of advanced drug delivery systems for biomacromolecules with improved efficiency of cargo encapsulation, efficient and precise cell targeting efficiency and superior stability for long-term storage and ease of global distribution is therefore crucial. Such technology for drug delivery would allow full realization of the transformative potential of biomacromolecules to prevent and treat disease. Dr. Chen’s research program aims to develop next-generation drug delivery systems for biomacromolecules by advancing materials design and nanofabrication technologies, as well as gaining a deeper knowledge of interactions between biomaterials and biological systems. The research program is divided into three themes, including novel nanocarriers for efficient and precise CRISPR-Cas9 delivery, advanced lipid nanoparticles for gene delivery, and bioresponsive nanoformulations for programmable protein delivery. The proposed research aligns exceptionally well with key aspects of McGill University’s Strategic Research Plan, including research pillars and strategic themes focused on nanoscience and advancing the biomedical and health sciences for healthy populations, and core commitments to fostering creativity and promoting equity, diversity, and inclusion (EDI) in research. With his multidisciplinary expertise and the support of the CRC program, Dr. Chen is well-positioned to make significant contributions to the field of biomaterials and biomacromolecule delivery.
McGill University - $120,000 Grant (2024-25) | Canada Spends